This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Tulane University. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: The Innovative Contributions of Sarah Vakili
Introduction
Sarah Vakili is a prominent inventor based in Philadelphia, PA. She has made significant strides in the field of biomedical research, particularly with her innovative work on MonoMac-1 cells. Her contributions are vital for advancing drug screening and evaluating drug candidates.
Latest Patents
Sarah Vakili holds a patent for her invention titled "MonoMac-1 cells expressing CD16 and CD163." This invention provides monocytes that express CD16 and CD163, creating an experimental system for drug screening or evaluating drug candidates where the modulation of these markers is desired. She has 1 patent to her name, showcasing her expertise and dedication to her field.
Career Highlights
Sarah is affiliated with Tulane University, where she continues her research and development efforts. Her work is instrumental in enhancing the understanding of monocyte behavior and its implications in drug development.
Collaborations
One of her notable collaborators is Jay F Rappaport, with whom she has worked closely on various projects. Their partnership has contributed to the advancement of their research initiatives.
Conclusion
In summary, Sarah Vakili's innovative work and her patent on MonoMac-1 cells represent significant advancements in biomedical research. Her contributions are paving the way for future developments in drug screening and evaluation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile